Decision to list medical devices supplied by Culpan Distributors Limited
We are pleased to announce the approval of listing agreements for the supply of medical devices to DHBs.
What we’re doing
We are pleased to announce the approval of a listing agreement with Culpan Distributors Limited (“Culpan”) for the supply of:
Any changes to the original proposal?
There has been a change from that initial consultation. The products in the category of non-dedicated and consumable infusion devices are no longer part of this listing agreement, as they are already available from Culpan on the pharmaceutical schedule under the category of surgical suction.
Who we think will be most interested
- Suppliers and wholesalers
- DHB clinical staff in a range of different clinical settings including:
- central sterile services personnel
- general wards
- infection control
- inpatient, outpatient and community settings
- DHB procurement and supply chain personnel
- Other clinical care providers such as ambulance and hospice providers.
Details about this decision
This RFP is for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac is working with a range of suppliers to seek provisional agreements in this category, this proposal is the latest to arise from these processes.
After completing the RFP evaluation process, and consulting on the provisional Agreement reached with Culpan, Pharmac has decided to list Culpan’s medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 September 2021.
DHBs can continue to choose which surgical drapes, gowns and procedure packs they purchase, including those from other suppliers. DHBs that purchase medical devices in the categories above, from Culpan, must do so under the terms and conditions, including pricing, in the Agreement, from 1 September 2021.
Our response to what you told us
Consultation on this proposal was open from 13 July to 3 August 2021. We appreciate the time people took to respond to this consultation.
All consultation responses received by the closing date were considered in their entirety in making the decision to list medical devices supplied by Culpan.
A summary of the main themes raised in feedback and our responses to the feedback are set out below:
No technical or resource impacts anticipated as a result of the proposal.
Support for listing the medical devices and that the agreement is not for sole supply.
If you have any questions about this decision, you can email us at email@example.com; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.